Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suning Chen

Showing results (191-200 of 368) with videos related to

Pageof 37
Sort By:
Molecular Cytogenetics|March 7, 2017
Multiple <i>MYO18A</i>-<i>PDGFRB</i> fusion transcripts in a myeloproliferative neoplasm patient with t(5;17)(q32;q11)Guangying Sheng, Zhao Zeng, Jinlan Pan, et al.
British Journal of Haematology|December 6, 2019
Identification of a novel TFG-FGFR1 fusion gene in an acute myeloid leukaemia patient with t(3;8)(q12;p11)Tingjing Wang, Zheng Wang, Ling Zhang, et al.
Clinical and Translational Medicine|October 26, 2023
CD19/CD22 dual-targeting chimeric antigen receptor T-cell therapy bridging to allogeneic haematopoietic stem cell transplantation for B-cell acute lymphoblastic leukaemia delays platelet recovery and increases risks of cytomegalovirus and Epstein-Barr virus viremia after transplantationShijia Li, Jianrong Ge, Shiyuan Zhou, et al.
Leukemia & Lymphoma|July 2, 2019
Clinical characteristics and prognostic significance of chronic myeloid leukemia with rare BCR-ABL1 transcriptsMengxing Xue, Qinrong Wang, Li Huo, et al.
Clinical Case Reports|January 27, 2023
Insights from a rare myeloproliferative neoplasm with coexisting <i>BCR-ABL1</i> fusion gene, <i>CALR,</i> and <i>TET2</i> mutations treated with nilotinib and ruxolitinibLi Huo, Jundan Xie, Qian Wang, et al.
Stem Cell Research & Therapy|January 28, 2024
Allogenic hematopoietic stem cell transplantation outcomes of patients aged ≥ 55 years with acute myeloid leukemia or myelodysplastic syndromes in China: a retrospective studyLu Gao, Li Yang, Shiyuan Zhou, et al.
Blood Cancer Journal|April 24, 2024
Combined emapalumab and ruxolitinib in patients with haemophagocytic LymphohistiocytosisYue Song, Fei Zhou, Feng Du, et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics|February 1, 2019
[Molecular cytogenetic characterization of five patients with myeloid leukemia and t(12;22)(p13;q12)]Haigang Shao, Qian Yang, Yanlei Gong, et al.
Cancer Genetics|April 5, 2014
The characteristics and prognostic analysis in 213 myeloid malignancy patients with del(20q): a report of a single-center case seriesJinlan Pan, Chunxiao Wu, Yongquan Xue, et al.
Leukemia & Lymphoma|April 6, 2019
Gene mutations and pretransplant minimal residual disease predict risk of relapse in adult patients after allogeneic hematopoietic stem-cell transplantation for T cell acute lymphoblastic leukemiaMingzhu Xu, Hong Liu, Yuejun Liu, et al.
Pageof 37

Showing results (191-200 of 368) with videos related to

Sort By:
Pageof 37
Molecular Cytogenetics|March 7, 2017
Multiple <i>MYO18A</i>-<i>PDGFRB</i> fusion transcripts in a myeloproliferative neoplasm patient with t(5;17)(q32;q11)Guangying Sheng, Zhao Zeng, Jinlan Pan, et al.
British Journal of Haematology|December 6, 2019
Identification of a novel TFG-FGFR1 fusion gene in an acute myeloid leukaemia patient with t(3;8)(q12;p11)Tingjing Wang, Zheng Wang, Ling Zhang, et al.
Clinical and Translational Medicine|October 26, 2023
CD19/CD22 dual-targeting chimeric antigen receptor T-cell therapy bridging to allogeneic haematopoietic stem cell transplantation for B-cell acute lymphoblastic leukaemia delays platelet recovery and increases risks of cytomegalovirus and Epstein-Barr virus viremia after transplantationShijia Li, Jianrong Ge, Shiyuan Zhou, et al.
Leukemia & Lymphoma|July 2, 2019
Clinical characteristics and prognostic significance of chronic myeloid leukemia with rare BCR-ABL1 transcriptsMengxing Xue, Qinrong Wang, Li Huo, et al.
Clinical Case Reports|January 27, 2023
Insights from a rare myeloproliferative neoplasm with coexisting <i>BCR-ABL1</i> fusion gene, <i>CALR,</i> and <i>TET2</i> mutations treated with nilotinib and ruxolitinibLi Huo, Jundan Xie, Qian Wang, et al.
Stem Cell Research & Therapy|January 28, 2024
Allogenic hematopoietic stem cell transplantation outcomes of patients aged ≥ 55 years with acute myeloid leukemia or myelodysplastic syndromes in China: a retrospective studyLu Gao, Li Yang, Shiyuan Zhou, et al.
Blood Cancer Journal|April 24, 2024
Combined emapalumab and ruxolitinib in patients with haemophagocytic LymphohistiocytosisYue Song, Fei Zhou, Feng Du, et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics|February 1, 2019
[Molecular cytogenetic characterization of five patients with myeloid leukemia and t(12;22)(p13;q12)]Haigang Shao, Qian Yang, Yanlei Gong, et al.
Cancer Genetics|April 5, 2014
The characteristics and prognostic analysis in 213 myeloid malignancy patients with del(20q): a report of a single-center case seriesJinlan Pan, Chunxiao Wu, Yongquan Xue, et al.
Leukemia & Lymphoma|April 6, 2019
Gene mutations and pretransplant minimal residual disease predict risk of relapse in adult patients after allogeneic hematopoietic stem-cell transplantation for T cell acute lymphoblastic leukemiaMingzhu Xu, Hong Liu, Yuejun Liu, et al.
Pageof 37